Used in pharmaceutical research as a key intermediate in the synthesis of selective dopamine D3 receptor antagonists. Shows potential in developing treatments for neurological disorders such as schizophrenia, drug addiction, and Parkinson’s disease. Its structure allows for high receptor subtype selectivity, improving drug efficacy and reducing side effects. Also investigated for use in radiolabeled forms for brain imaging studies.